Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1987;65(6):861–868.

Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-1983

L Spanjaard, P Bol, S de Marie, H C Zanen
PMCID: PMC2491086  PMID: 3124970

Abstract

To study the association of meningococcal serogroups with the course of disease, we reviewed the case histories of 1221 patients. The meningococci from these patients constituted a sample from isolates collected and serogrouped systematically in the Netherlands since 1959. Of these 1221 isolates, 64% were serogroup B. The overall case fatality rate was 5.1%, and the rate was lowest for patients with serogroup A infections (2.3%) and highest for serogroup W135 (18%) (P < 0.01). The occurrence of septicaemia without meningitis (case fatality rate 15.3%) was similarly distributed among the serogroups (A, 4.0%; W135, 30%). Sequelae occurred in 7.9% of patients (loss of hearing, 3.2%) and were remarkably prevalent after disease due to minor serogroups (X and Y: 4 out of 12). In a log-linear analysis, both age and serogroup were significantly associated with case fatality rate and with the occurrence of septicaemia and sequelae. It is argued that these data are representative, despite the problems inherent in a retrospective investigation. The course and outcome of meningococcal disease appear to be related to the Neisseria meningitidis serogroup and to host factors.

Full text

PDF
865

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashton F. E., Ryan A., Diena B., Jennings H. J. A new serogroup (L) of Neisseria meningitidis. J Clin Microbiol. 1983 May;17(5):722–727. doi: 10.1128/jcm.17.5.722-727.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Band J. D., Chamberland M. E., Platt T., Weaver R. E., Thornsberry C., Fraser D. W. Trends in meningococcal disease in the United States, 1975-1980. J Infect Dis. 1983 Oct;148(4):754–758. doi: 10.1093/infdis/148.4.754. [DOI] [PubMed] [Google Scholar]
  3. Bay D., Aasen S., Lystad A. Meningococcal disease in Norway 1980--83. NIPH Ann. 1983 Dec;6(2):151–153. [PubMed] [Google Scholar]
  4. Brandstetter R. D., Blair R. J., Roberts R. B. Neisseria meningitidis serogroup W 135 disease in adults. JAMA. 1981 Nov 6;246(18):2060–2061. [PubMed] [Google Scholar]
  5. Counts G. W., Petersdorf R. G. 'The wheel within a wheel': meningococcal trends. JAMA. 1980 Nov 14;244(19):2200–2201. [PubMed] [Google Scholar]
  6. De Wals P., Hertoghe L., Reginster G., Borlee I., Bouckaert A., Dachy A., Lechat M. F. Mortality in meningococcal disease in Belgium. J Infect. 1984 May;8(3):264–273. doi: 10.1016/s0163-4453(84)94123-9. [DOI] [PubMed] [Google Scholar]
  7. Dodge P. R., Davis H., Feigin R. D., Holmes S. J., Kaplan S. L., Jubelirer D. P., Stechenberg B. W., Hirsh S. K. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med. 1984 Oct 4;311(14):869–874. doi: 10.1056/NEJM198410043111401. [DOI] [PubMed] [Google Scholar]
  8. Evans-Jones L. G., Whittle H. C., Onyewotu I. I., Egler L. J., Greenwood B. M. Comparative study of group A and group C meningococcal infection. Arch Dis Child. 1977 Apr;52(4):320–323. doi: 10.1136/adc.52.4.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fallon R. J., Brown W. M., Lore W. Meningococcal infections in Scotland 1972-82. J Hyg (Lond) 1984 Oct;93(2):167–180. doi: 10.1017/s0022172400064688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Finne J., Leinonen M., Mäkelä P. H. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet. 1983 Aug 13;2(8346):355–357. doi: 10.1016/s0140-6736(83)90340-9. [DOI] [PubMed] [Google Scholar]
  11. Frasch C. E., Zollinger W. D., Poolman J. T. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis. 1985 Jul-Aug;7(4):504–510. doi: 10.1093/clinids/7.4.504. [DOI] [PubMed] [Google Scholar]
  12. Galaid E. I., Cherubin C. E., Marr J. S., Schaefler S., Barone J., Lee W. Meningococcal disease in New York City, 1973 to 1978. Recognition of groups y and W-135 as frequent pathogens. JAMA. 1980 Nov 14;244(19):2167–2171. [PubMed] [Google Scholar]
  13. Hardman J. M. Fatal meningococcal infections: the changing pathologic picture in the '60s. Mil Med. 1968 Dec;133(12):951–964. [PubMed] [Google Scholar]
  14. Holten E., Frøholm L. O., Gaustad P. Virulence markers in patient and carrier strains of Neisseria meningitidis. Scand J Infect Dis. 1984;16(3):267–270. doi: 10.3109/00365548409070399. [DOI] [PubMed] [Google Scholar]
  15. Moss P. D. Outcome of meningococcal group B meningitis. Arch Dis Child. 1982 Aug;57(8):616–621. doi: 10.1136/adc.57.8.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Peltola H., Jónsdóttir K., Lystad A., Sievers C. J., Kallings I. Meningococcal disease in Scandinavia. Br Med J (Clin Res Ed) 1982 May 29;284(6329):1618–1621. doi: 10.1136/bmj.284.6329.1618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Peltola H. Meningococcal disease: still with us. Rev Infect Dis. 1983 Jan-Feb;5(1):71–91. doi: 10.1093/clinids/5.1.71. [DOI] [PubMed] [Google Scholar]
  18. Salit I. E. Meningococcemia caused by serogroup W135. Association with hypogammaglobulinemia. Arch Intern Med. 1981 Apr;141(5):664–665. [PubMed] [Google Scholar]
  19. Schlech W. F., 3rd, Ward J. I., Band J. D., Hightower A., Fraser D. W., Broome C. V. Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA. 1985 Mar 22;253(12):1749–1754. [PubMed] [Google Scholar]
  20. Spanjaard L., Bol P., de Marie S., Zanen H. C. Age-distribution of meningococcal disease as predictor of epidemics. Lancet. 1982 Nov 6;2(8306):1039–1040. doi: 10.1016/s0140-6736(82)90065-4. [DOI] [PubMed] [Google Scholar]
  21. Spanjaard L., Bol P., de Marie S., Zanen H. C. Association of meningococcal serotypes with the course of disease: serotypes 2a and 2b in the Netherlands, 1959-1981. J Infect Dis. 1987 Feb;155(2):277–282. doi: 10.1093/infdis/155.2.277. [DOI] [PubMed] [Google Scholar]
  22. de Marie S., Poolman J. T., Hoeijmakers J. H., Bol P., Spanjaard L., Zanen H. C. Meningococcal disease in The Netherlands, 1959-1981: the occurrence of serogroups and serotypes 2a and 2b of Neisseria meningitidis. J Infect. 1986 Mar;12(2):133–143. doi: 10.1016/s0163-4453(86)93583-8. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES